checkAd

     133  0 Kommentare Genetron Health Announces Completion of Going Private Transaction - Seite 3

    Safe Harbor Statement

    This press release contains forward-looking statements made under the “safe harbor” provisions of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Genetron Health may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Genetron Health’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Genetron Health’s filings with the SEC. All information provided in this announcement and in the attachments is as of the date of this press release, and Genetron Health does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    Investor Relations Contact
    Email: ir@genetronhealth.com


    Seite 3 von 3




    globenewswire
    0 Follower
    Autor folgen
    Verfasst von globenewswire
    Genetron Health Announces Completion of Going Private Transaction - Seite 3 BEIJING, March 28, 2024 (GLOBE NEWSWIRE) - Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer …